Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat-Reference-Cited by-同舟云学术

Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat

Published:2013 Issue:1 Volume:12 Page:148
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Bao Weike,Holt Lucy J,Prince Rob D,Jones Gavin X,Aravindhan Karpagam,Szapacs Mathew,Barbour April M,Jolivette Larry J,Lepore John J,Willette Robert N,DeAngelis Elena,Jucker Beat M

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Biology of Incretins: GLP-1 and GIP

2. New treatments in type 2 diabetes: a focus on the incretin-based therapies

3. Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

4. Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury

5. Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

2. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30

3. Human serum albumin binders: A piggyback ride for long-acting therapeutics;Drug Discovery Today;2023-10

4. Peptides with therapeutic applications from microbial origin;Recent Advances and Future Perspectives of Microbial Metabolites;2023

5. Derivatization with fatty acids in peptide and protein drug discovery;Nature Reviews Drug Discovery;2022-08-24